Subscribe to PRO at just Rs.33 per month. Use code SUPERPRO
you are here: HomeNewsBusiness
Last Updated : Jul 02, 2020 06:44 PM IST | Source: Reuters

Singapore's Temasek delays annual report due to coronavirus pandemic

'To accommodate this delay of global consolidation for financial reporting, Temasek's own annual reporting will be delayed from July till September,' Ho said.


Singapore state investor Temasek Holdings said on Thursday it had delayed its annual report until September as the coronavirus pandemic had affected financial reporting for many of its portfolio companies.

CEO Ho Ching announced the delay in a Facebook post, noting that Temasek's portfolio companies had businesses spread across many countries. Temasek was set to release its report this month.

"To accommodate this delay of global consolidation for financial reporting, Temasek's own annual reporting will be delayed from July till September," Ho said.


In the year to March 31, 2019, Temasek's net portfolio value grew 1.6% to a record S$313 billion ($224.6 billion). It had a 66% exposure to Asia by underlying assets.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more

"Although we didn't anticipate a COVID pandemic, the economic indicators had become worrisome since last year," Ho said, adding that Temasek had been making plans to beef up its balance sheet further.

"This has come in handy as we work through the COVID crisis that is threatening to bring on global recession. Clearly, COVID is now a bigger problem than we had expected," she said.

After the pandemic outbreak, Temasek led a multi-billion dollar rescue package for Singapore Airlines and supported a rights issue by money-losing rig builder Sembcorp Marine.

First Published on Jul 2, 2020 06:42 pm